August 5, 2020

Volume X, Number 218

August 04, 2020

Subscribe to Latest Legal News and Analysis

August 03, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
2
Nov
Ghana Achieves “Zero Hunger” Covington & Burling LLP
31
Oct
FDA and the Center for Food Safety Reach Settlement Regarding FDA’s GRAS Rule Mintz
30
Oct
Ariosa Diagnostics v. Verinata Health, Inc.: Final Written Decision IPR2014-00276 Faegre Drinker
30
Oct
Biometric Screening Requirement Under Wellness Program Violates ADA and GINA, According to EEOC Suit Jackson Lewis P.C.
30
Oct
Medical Device Update: Distinguishing Medical Device Recalls from Medical Device Enhancements Morgan, Lewis & Bockius LLP
29
Oct
Marijuana Users in Michigan Eligible for Unemployment Proskauer Rose LLP
29
Oct
Progress Update: House Energy and Commerce Committee (E&C) 21st Century Cures Initiative McDermott Will & Emery
29
Oct
Ebola Exclusions from Commercial Insurance Policies Mintz
29
Oct
U.S. Immigration Policy Catches Up with Assisted Reproductive Technology Mintz
29
Oct
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 Covington & Burling LLP
29
Oct
Government Looking to Existing Procurement Vehicles to Stem Ebola Threat Covington & Burling LLP
28
Oct
Texas Federal Jury Sides with J&J’s DePuy In First Pinnacle Hip Implant Trial Covington & Burling LLP
28
Oct
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates McDermott Will & Emery
28
Oct
Bostwick Laboratories Agrees to Pay U.S. Government $6.05 Million for Allegedly Violating the Anti-Kickback Statue; Whistleblower to Receive Reward Tycko & Zavareei LLP
28
Oct
Michigan Medical Marijuana Law Allows Employees Terminated for Positive Marijuana Test Results to Receive Unemployment Benefits Jackson Lewis P.C.
27
Oct
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
25
Oct
EPA Updates Toxic Substances Control Act (TSCA) Work Plan for Chemical Assessments Beveridge & Diamond PC
24
Oct
FTC Takes Action Against Unsubstantiated Caffeine-Infused Shapewear Weight-Loss Claims Sheppard, Mullin, Richter & Hampton LLP
23
Oct
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 Mintz
23
Oct
Uncertain Times for Biotech and Pharma Patents Vedder Price

Pages

TRENDING LEGAL ANALYSIS